Endothelial nitric oxide synthase single nucleotide polymorphism and left ventricular function in early chronic kidney disease

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Chand, Sourabh ^a,b   Chue, Colin D ^a   Edwards, Nicola C ^a   Hodson, James ^a   Simmonds, Matthew J ^c   Hamilton, Alexander ^c   Gough, Stephen C L ^c,d   Harper, Lorraine ^a,b   Steeds, Rick P ^a   Townend, Jonathan N ^a   Ferro, Charles J ^a   Borrows, Richard ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DOPPLER IMAGING; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; GENETICS; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; RADIOGRAPHY;

AGED; C-REACTIVE PROTEIN; CHOLESTEROL; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; RENAL INSUFFICIENCY, CHRONIC; VENTRICULAR FUNCTION, LEFT;

EID: 84921716934     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116160     Document Type: Article

References (25)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047. doi: 10.1001/jama.298.17.2038 PMID: 17986697
2. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-2081. doi: 10.1016/S0140-6736(10) 60674-5 PMID: 20483451
3. Chue CD, Townend JN, Steeds RP, Ferro CJ (2010) Arterial stiffness in chronic kidney disease: causes and consequences. Heart 96: 817-823. doi: 10.1136/hrt.2009.184879 PMID: 20406771
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305. doi: 10.1056/ NEJMoa041031 PMID: 15385656
5. Ferguson JF, Matthews GJ, Townsend RR, Raj DS, Kanetsky PA, et al. (2013) Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort). J Am Coll Cardiol 62: 789-798. doi: 10.1016/j.jacc.2013.01.103 PMID: 23727086
6. McNamara DM, Holubkov R, Postava L, Ramani R, Janosko K, et al. (2003) Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation 107: 1598-1602. doi: 10.1161/01.CIR.0000060540.93836.AA PMID: 12668492
7. Velloso MW, Pereira SB, Gouveia L, Chermont S, Tardin OM, et al. (2010) Endothelial nitric oxide synthase Glu298Asp gene polymorphism in a multi-ethnical population with heart failure and controls. Nitric oxide 22: 220-225. doi: 10.1016/j.niox.2009.12.007 PMID: 20079452
8. Page A, Reich H, Zhou J, Lai V, Cattran DC, et al. (2005) Endothelial nitric oxide synthase gene/gender interactions and the renal hemodynamic response to angiotensin II. J Am Soc Nephrol 16: 3053-3060. doi: 10.1681/ASN.2004110905 PMID: 16093452
9. Edwards NC, Ferro CJ, Kirkwood H, Chue CD, Young AA, et al. (2010) Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease. Am J Cardiol 106: 1505-1511. doi: 10.1016/j.amjcard.2010.07.018 PMID: 21059444
10. Chue CD, Townend JN, Moody WE, Zehnder D, Wall NA, et al. (2013) Cardiovascular effects of sevelamer in stage 3 CKD. J Am Soc Nephrol 24: 842-852. doi: 10.1681/ASN.2012070719 PMID: 23599381
11. Stringer S, Sharma P, Dutton M, Jesky M, Ng K, et al. (2013) The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol. BMC Nephrol 14: 95. doi: 10.1186/1471-2369-14-95 PMID: 23617441
12. Testa A, Spoto B, Sanguedolce MC, Parlongo RM, Pisano A, et al. (2012) eNOS and caveolin-1 gene polymorphisms interaction and intima media thickness: a proof of concept study in ESRD patients. Am J Hypertens 25: 103-108. doi: 10.1038/ajh.2011.178 PMID: 21976276
13. Maceira AM, Prasad SK, Khan M, Pennell DJ (2006) Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 8: 417-426. doi: 10.1080/10976640600572889 PMID: 16755827
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463. doi: 10.1016/j.echo.2005.10.005 PMID: 16376782
15. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, et al. (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22: 107-133. doi: 10.1016/j.echo.2008.11.023 PMID: 19187853
16. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, et al. (1998) Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16: 2079-2084. doi: 10.1097/00004872-199816121-00033 PMID: 9886900
17. Chapman CB, Ewer SM, Kelly AF, Jacobson KM, Leal MA, et al. (2013) Classification of left ventricular diastolic function using American Society of Echocardiography Guidelines: agreement among echocardiographers. Echocardiography 30: 1022-1031. doi: http://dx.doi.org/10.1111/echo.12185 PMID: 23551740
18. Tardin OM, Pereira SB, Velloso MW, Balieiro HM, Costa B, et al. (2013) Genetic polymorphism G894T and the prognosis of heart failure outpatients. Arq Bras Cardiol 101: 352-358. doi: http://dx.doi.org/10. 5935/abc.20130167 PMID: 23949326
19. Zhang X, Lynch AI, Davis BR, Ford CE, Boerwinkle E, et al. (2012) Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study. PloS One 7: e34217. doi: 10.1371/journal.pone.0034217 PMID: 22470539
20. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, et al. (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 97: 2832-2835. doi: 10.1073/pnas.97.6.2832 PMID: 10717002
21. Massion PB, Dessy C, Desjardins F, Pelat M, Havaux X, et al. (2004) Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 110: 2666-2672. doi: 10.1161/01.CIR. 0000145608.80855.BC PMID: 15492314
22. Philip I, Plantefeve G, Vuillaumier-Barrot S, Vicaut E, LeMarie C, et al. (1999) G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation 99: 3096-3098. doi: 10.1161/01.CIR.99.24.3096 PMID: 10377070
23. Brunner F, Andrew P, Wolkart G, Zechner R, Mayer B (2001) Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104: 3097-3102. doi: 10.1161/hc5001.101966 PMID: 11748107
24. Massy ZA, Stenvinkel P, Drueke TB (2009) The role of oxidative stress in chronic kidney disease. Semin Dial 22: 405-408. doi: 10.1111/j.1525-139X.2009.00590.x PMID: 19708991
25. Tang L, Wang H, Ziolo MT (2014) Targeting NOS as a therapeutic approach for heart failure. Pharmacol Ther Jun; 142(3):306-15. doi: 10.1016/j.pharmthera.2013.12.013 PMID: 24380841